title: Monitoring anti-inflammatory therapies in patients with atherosclerosis: FDG PET emerges as the method of choice.
authors.forename: M
authors.initials: M
authors.lastname: Hacker
mesh_terms: D050153:Abdominal Fat / Q000187:drug effects*; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001167:Arteritis / Q000188:drug therapy*; D000069059:Atorvastatin; D005260:Female; D006538:Heptanoic Acids / Q000494:pharmacology*; D006801:Humans; D008297:Male; D011758:Pyrroles / Q000494:pharmacology*; D061205:Vascular Calcification / Q000188:drug therapy*
chemical_list: D000893:Anti-Inflammatory Agents; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin